Skinvisible, Inc.
SKVI
$0.35
-$0.18-33.78%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A Expenses | -14.60% | -4.69% | 13.28% | 45.25% | 9.15% |
| Depreciation & Amortization | -13.56% | 6.25% | 4.26% | 8.51% | 31.11% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.54% | -4.40% | 13.03% | 43.96% | 10.08% |
| Operating Income | 15.12% | 4.56% | -13.56% | -45.57% | -10.52% |
| Income Before Tax | 12.70% | 9.56% | 3.24% | 203.62% | 0.31% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 12.70% | 9.56% | 3.24% | 203.62% | 0.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.70% | 9.56% | 3.24% | 203.62% | 0.31% |
| EBIT | 15.12% | 4.56% | -13.56% | -45.57% | -10.52% |
| EBITDA | 15.21% | 4.86% | -13.84% | -46.97% | -9.58% |
| EPS Basic | 26.62% | 23.95% | 18.13% | 171.00% | 0.32% |
| Normalized Basic EPS | 26.84% | 24.16% | 18.25% | 13.64% | 0.25% |
| EPS Diluted | 26.62% | 23.95% | 18.13% | 169.06% | 0.32% |
| Normalized Diluted EPS | 26.84% | 24.16% | 18.25% | 13.64% | 0.25% |
| Average Basic Shares Outstanding | 19.03% | 19.03% | 18.13% | 45.95% | 0.00% |
| Average Diluted Shares Outstanding | 19.03% | 19.03% | 18.13% | 45.95% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |